Volumetric Muscle Loss (VML) is a specific type of muscle injury characterized by the significant loss of muscle tissue volume, typically resulting from severe trauma, surgical intervention, or other traumatic events. Unlike typical muscle injuries, VML involves the removal or destruction of a substantial amount of muscle mass, impairing the affected muscle's structure and function. In VML, the body's natural regenerative mechanisms struggle to repair the extensive muscle loss, leading to functional deficits and chronic impairment. The condition often occurs in conjunction with damage to blood vessels and nerves within the muscle, further complicating the recovery process. Rehabilitation strategies for VML focus on stimulating muscle regeneration and preventing fibrotic tissue formation. Researchers explore various approaches, including stem cell therapy, tissue engineering, and regenerative medicine, to enhance muscle regeneration and functional recovery in individuals with VML. The long-term consequences of VML can be profound, impacting not only muscle strength and mobility but also contributing to secondary issues such as joint instability and altered biomechanics. Managing VML requires a multidisciplinary approach involving physical therapy, surgical interventions, and innovative regenerative therapies to address the complex challenges associated with significant muscle loss.
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cells for human disease modelling and potential for tissue repair
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : Personalized and Precision Medicine (PPM): A unique healthcare model via pathology-related modelling and bi-odesign-inspired translational applications for the next gen-eration of human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation